Experienced in High Potassium Level

Lei H. Cheng

83 FenYang Road, 
Shanghai, CN 
Experienced in High Potassium Level
83 FenYang Road, 
Shanghai, CN 
OverviewLocationsClinical Research

Overview

Lei Cheng practices in Shanghai, China. Ms. Cheng is rated as an Experienced expert by MediFind in the treatment of High Potassium Level. Her top areas of expertise are Allergic Rhinitis, Leukoplakia, Thrush, Laryngectomy, and Endoscopy.

Her clinical research consists of co-authoring 942 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of High Potassium Level.

Gender
Female

Locations

83 FenYang Road, Shanghai, 200031, China
Other Locations
Huaihai West Road No.241, Huaihai, 200030, China
No. 507, Zheng Min Road, Shanghai, 200433, China
Renmin South Road, Chengdu, 610041, China
1 Banshandong Road, Hangzhou, 310022, China
29 Wangjiang Road, Chengdu, 610064, China
305 Fenglin Road, Shanghai, 200032, China
State Key Laboratory Of Bioreactor Engineering, Shanghai, 200237, China
No. 321 Zhongshan Road, Nanjing, 210008, China
321 Zhongshan Road, Nanjing, 210008, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomised, Double-blind, Placebo Controlled, Parallel Group Phase III Study to Assess the Clinical Efficacy and Safety of 100 mg SC Mepolizumab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) / Eosinophilic Chronic Rhinosinusitis (ECRS) MERIT: Mepolizumab in Eosinophilic Chronic RhinosinusITis Study
A Randomised, Double-blind, Placebo Controlled, Parallel Group Phase III Study to Assess the Clinical Efficacy and Safety of 100 mg SC Mepolizumab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) / Eosinophilic Chronic Rhinosinusitis (ECRS) MERIT: Mepolizumab in Eosinophilic Chronic RhinosinusITis Study
Enrollment Status: Completed
Publish Date: November 25, 2024
Intervention Type: Drug
Study Drugs: Mepolizumab, Standard of Care
Study Phase: Phase 3

942 Total Publications

Publisher Correction: Periodontitis-associated Fusobacterium nucleatum promotes ulcerative colitis by ferroptosis-mediated gut barrier disruption.
Publisher Correction: Periodontitis-associated Fusobacterium nucleatum promotes ulcerative colitis by ferroptosis-mediated gut barrier disruption.
Journal: NPJ biofilms and microbiomes
Published: October 01, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Cheng's expertise for a condition
ConditionClose
View All 11 Advanced Conditions
View All 72 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile